SARASOTA, Fla. - January 7, 2020 - (Newswire.com)
Three North American companies in the healthcare industry have announced their quarterly earnings reports to be made public the week of January 6th, 2020. AngioDynamics, Inc. (ANGO), will report quarterly earnings on Jan. 7, 2020, while Walgreens Boots Alliance, Inc. (WBA), and Advaxis, Inc. (ADXS) will both report earnings on Jan. 8, 2020.
AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology based in Latham, New York. Following the company’s announcement of the departure of its CFO Michael Greiner in October 2019, the company states: “Mr. Greiner will remain with AngioDynamics to facilitate a smooth transition of duties up to the filing of the second fiscal quarter 10-Q, and the Company has initiated a process to determine a permanent successor.” The Company is reaffirming its previously issued financial guidance for fiscal year 2020.
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company based in Deerfield, Illinois. With the Walgreens Boots Alliance and McKesson joint venture announcement and its affiliate Boots retail expansion in Indonesia, the company continues to expand its more than 25 countries and will add more locations to its portfolio of more than 18,750 stores.
Adavaxis, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products that operate out of Princeton, New Jersey.
Most notably, the company has announced it has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 1 clinical study of ADXS-504, the Company’s ADXS-HOT drug candidate for prostate cancer. According to a recent press release, the company states: “Results from our ADXS-NEO program provided important proof-of-concept data demonstrating the generation of CD8+ T cells against hotspot mutations.”
Market expectations based on upcoming earning reports have a direct impact on stock prices. These earnings reports provide critical financial updates that can shed light on how stocks may be valued at a later date and how it may impact investors and stockholders. For nascent companies looking to generate interest, earnings reports are a useful way to underscore company growth and give an indication of how well they are performing. 2020 is slated to see an uptrend in continued innovation in the medical and healthcare sector.
PressRelease.com offers affordable regulatory compliant press release distribution for publicly traded companies looking to grow their reach in the new year. With PressRelease.com, publicly traded companies get distribution to leading financial media outlets, delivery to investor networks, and SEC compliant disclosures. For continued news updates of healthcare businesses and regulatory-compliant press release content, visit PressRelease.com.
About PressRelease.com
PressRelease.com provides simple, flexible, and cost-effective press release distribution services to public and private companies through the most comprehensive networks and media contacts. Through its strategic alliance with Newswire, PressRelease.com can now offer the Earned Media Advantage Guided Tour provided by Newswire to clients.
Contact Information:
PressRelease.com
Media Relations
Office: 800-998-2927
Email: support@pressrelease.com
Press Release Service by Newswire.com
Original Source: Healthcare Companies Announce Earnings Reports
